4 January 2022

The SII Anti-Doping Monitor – week ending 31 December 2021

Fifteen athletes competing in eight sports, from eight countries, were involved in anti-doping proceedings in the last week of 2021. The majority of cases involved confirmed anti-doping rule violations (ADRVs). Only two involved adverse analytical findings (AAFs – or ‘positive tests’) that have yet to be confirmed as ADRVs.

Jovan Lekic is to lose medals won at both a domestic meet and the European Junior Swimming Championships. Lekic finished second in the 100m freestyle at the International Swimming Competition in Belgrade; and won Silver in the 400m freestyle and Bronze in the 200m freestyle at the European Juniors. An AAF for higenamine at both events means his results from both events will be disqualified.

Higenamine is featured as a Beta-2 Agonist on the World Anti-Doping Agency’s (WADA) Prohibited List, despite the Mamadou Sakho case casting doubt on whether it is a Beta-2 Agonist at all. It is a substance that can be produced by certain plants, and is sometimes included as an ingredient in supplements.

The Polish Anti-Doping Agency (POLADA) has confirmed that boxer Sebastian Wiktorzak has been provisionally suspended after returning an AAF for GHRP-2. ‘We are waiting for the athlete’s decision regarding B sample analysis’, wrote a POLADA spokesperson in response to questions from The Sports Integrity Initiative. Wiktorzak’s unconfirmed AAF featured in last week’s SII Anti-Doping Monitor.

POLADA also confirmed that a hearing was held into Maciej Witan’s case on 16 December. The young ice hockey player has been provisionally suspended since 8 October. A test after Ciarko STS Sanok’s 16 September match against KH Energa Toruń resulted in an AAF for amphetamine.

Article 10.8.1 of the World Anti-Doping Code (click to open…)

Four Serbian bodybuilders who tested positive for prohibited substances at the national bodybuilding championships received one year reductions to a four year ban. Under Article 10.8.1 of the World Anti-Doping Code, athletes who admit an ADRV within 20 days of being charged can receive a one year reduction to a four year ban (see right).

Finally, Mexican cyclist Luis Ricardo Villalobos Hernandez was sanctioned with a four year ban expiring on 17 May 2024 for an ADRV involving GHRP-6, a growth hormone releasing peptide. On 18 May 2020, the international cycling union (UCI) announced that reanalysis of an out of competition sample taken on 25 April 2019 had returned an AAF. 

Please continue to send any cases we may have missed or suggestions through to our editor by clicking here. Also, if you’re an athlete, national anti-doping organisation (NADO) or other Results Management Authority and you’d like us to cover a case that you’re involved with, please get in touch!

Decisions

Luis Ricardo Villalobos Hernandez;
Michal Prazeres;
Amdou Diallo Diouf;
Alexandra Igoshina;
Alexander Isaev;
Vitaly Ugolnikov;
Alexei Becker;
Marat Gairbekov;
Sasa Dimitrijevic, Dusica Pavlovic, Luka Lazovic, and Bojana Komarica;
Jovan Lekic

You may also like...

Pin It on Pinterest

Share This